










































The human cytoplasmic RNA terminal U-transferase ZCCHC11
targets histone mRNAs for degradation
Citation for published version:
Schmidt, M-J, West, S & Norbury, CJ 2011, 'The human cytoplasmic RNA terminal U-transferase ZCCHC11
targets histone mRNAs for degradation' RNA, vol. 17, no. 1, pp. 39-44. DOI: 10.1261/rna.2252511
Digital Object Identifier (DOI):
10.1261/rna.2252511
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:




Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 05. Apr. 2019
REPORT
The human cytoplasmic RNA terminal U-transferase
ZCCHC11 targets histone mRNAs for degradation
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1University of Oxford, Sir William Dunn School of Pathology, Oxford OX1 3RE, United Kingdom
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ABSTRACT
Inhibition of eukaryotic DNA replication leads to the rapid suppression of histone synthesis, via 39 uridylation of cytoplasmic
histone mRNAs followed by their Lsm1–7-mediated decapping and degradation. Here we show that the human cytoplasmic
RNA terminal U-transferase ZCCHC11, recently implicated in microRNA metabolism, associates with replication-dependent
histone mRNAs. Knockdown of ZCCHC11 selectively blocked histone mRNA degradation following inhibition of DNA rep-
lication, whereas knockdown of PAPD1 or PAPD5, previously proposed as candidate histone mRNA U-transferases, had no such
effect. Furthermore, a reduction in the proportion of histone transcripts that were uridylated was observed following ZCCHC11
knockdown. Our data indicate that ZCCHC11 is the terminal U-transferase responsible for targeting human histone mRNAs for
degradation following inhibition or completion of DNA replication.
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INTRODUCTION
Histones have the capacity to interfere nonspecifically with
a variety of cellular processes, and hence to be toxic if they
accumulate to levels that exceed the capacity of the cell to
incorporate them into nucleosomes and chromatin (Osley
1991). Synthesis of most core histones is therefore tightly
linked to ongoing DNA replication during S phase; this is
achieved in large part by cell cycle-dependent changes in
histone mRNA levels.
The mRNAs encoding mammalian ‘‘replication-depen-
dent’’ histones lack poly(A) tails but instead share a charac-
teristic 39 stem–loop structure. Through its interaction with
a stem–loop binding protein (SLBP/HBP), this structure
mediates processing of precursor histone mRNAs in the
nucleus, the nuclear export, stability, and translational com-
petence of the mRNAs, as well as their specific regulation
in the cytoplasm (Dominski and Marzluff 1999). Inhibition
of DNA replication in mammalian cells, for example on ex-
posure to the ribonucleotide reductase inhibitor hydroxy-
urea (HU), leads to the rapid and selective degradation of
replication-dependent histonemRNAs. A number of cellular
factors or processes have been implicated in HU-induced
histone mRNA degradation, including SLBP/HBP, ongoing
translation, the signaling kinases ATR and DNA-PK, a 39–59
exonuclease termed 39hExo, and Upf1, a protein also in-
volved in nonsense-mediated mRNA decay (Dominski et al.
2003; Kaygun and Marzluff 2005; Muller et al. 2007).
A recent study further suggested that 39 oligouridylation
of replication-dependent histone mRNAs is a rate-limiting
step in their degradation both by 59–39 and by 39–59
exonuclease activities, and tentatively identified two enzymes
(PAPD1/hmtPAP/TUTase1 and PAPD5/TUTase3) as can-
didates for performing the oligouridylation step (Mullen and
Marzluff 2008). Here we describe data that implicate a dif-
ferent enzyme, the cytoplasmic RNA terminal U-transferase
ZCCHC11, as a rate-limiting mediator of histone mRNA
degradation.
RESULTS AND DISCUSSION
The reported involvement of PAPD1 and PAPD5 in cyto-
plasmic histone uridylation (Mullen and Marzluff 2008)
was unexpected for two reasons. Firstly, PAPD1 has been
identified as the enzyme (hmtPAP) responsible for poly-
adenylation of mitochondrial mRNAs, and immunofluores-
cence microscopy data suggest that it is an exclusively mito-
chondrial protein (Tomecki et al. 2004; Nagaike et al. 2005).
Reprint requests to: Chris J. Norbury, University of Oxford, Sir
William Dunn School of Pathology, South Parks Road, Oxford OX1
3RE, United Kingdom; e-mail: chris.norbury@path.ox.ac.uk; fax: +44
(0)1865 275501.
Article published online ahead of print. Article and publication date are
at http://www.rnajournal.org/cgi/doi/10.1261/rna.2252511.
RNA (2011), 17:39–44. Published by Cold Spring Harbor Laboratory Press. Copyright  2011 RNA Society. 39
Secondly, the amino acid sequence of PAPD5 indicates that it
is one of two human orthologs of the yeast Trf4/Trf5 poly(A)
polymerases, which are involved in adenylation-mediated
turnover of nuclear RNAs; furthermore, PAPD5was recently
shown to be responsible for the adenylation of incomplete
ribosomal RNA transcripts in the nucleus (Shcherbik et al.
2010). We therefore considered the possibility that other
RNA nucleotidyl transferase(s) might be responsible for
uridylation of cytoplasmic replication-dependent histone
mRNAs. PAPD1 and PAPD5 are members of a family of
seven related human proteins that have been described
as noncanonical poly(A) polymerases or as ribonucleotidyl
transferases that can incorporate residues other than AMP
(Schmidt and Norbury 2010). Three members of this family
have been found to have uridyl transferase activity and, of
these three, the nuclear enzyme RBM21 (U6TUTase) was
identified as a highly specific terminal U-transferase that
uridylates only the U6 snRNA (Trippe et al. 2006). The nu-
cleotide preference of the two remaining uridyl transferases,
ZCCHC6 and ZCCHC11, was initially identified by an
RNA tethering approach in Xenopus oocytes (Kwak and
Wickens 2007); the in vitro activity of ZCCHC6 as a terminal
U-transferase was also demonstrated using tandem affinity
purified enzyme from human cells (Rissland et al. 2007).
ZCCHC11 (with its orthologs in mouse and C. elegans) has
been the subject of much recent attention due to its identifi-
cation as the enzyme responsible for 39 uridylation of micro-
RNAs (miRNAs) and their cytoplasmicprecursors (Haganet al.
2009; Heo et al. 2009; Jones et al. 2009; Lehrbach et al. 2009).
Cytoplasmic ZCCHC11 associates with histone
H3 mRNA
We raised and affinity-purified a polyclonal antibody against
recombinant ZCCHC11. Western blotting of fractionated
human HEK293T cell extracts with this antibody indicated
that ZCCHC11 is an exclusively cytoplasmic protein (Fig.
1A), in agreement with recently described immunofluo-
rescence microscopy of endogenous ZCCHC11 (Heo et al.
2009). Our antibody was also able to immunoprecipitate
ZCCHC11 from nondenaturing cell lysates (Fig. 1B), which
allowed us to test directly the possibility that ZCCHC11
might be associated with replication-dependent histone
mRNAs. After formaldehyde cross-linking, immunoprecip-
itation, and RT-PCR, we were able to detect replication-
dependent histone H3 (HIST2H3) mRNA specifically in
association with ZCCHC11, but not with ZCCHC6 (Fig.
1C,D). Both proteins were readily detectable by Western
blotting (data not shown), suggesting that failure to recover
HIST2H3 in association with ZCCHC6 is not simply due to
a lack of ZCCHC6 protein in these cells. In contrast, GAPDH
mRNA, a control mRNA representative of those not subject
to S phase arrest-specific degradation, was not specifically
immunoprecipitated by either antibody. These data indicate
that ZCCHC11 can bind to histone mRNAs in vivo.
ZCCHC11 is required for efficient histone
mRNA turnover
Its association with HIST2H3 mRNA suggested a potential
role for ZCCHC11 in histone mRNA degradation. To test
this possibility, we expressed a short hairpin RNA (shRNA)
corresponding to a sequence in theZCCHC11 39UTR to knock
down ZCCHC11 expression in HEK293T cells (Fig. 2A,B).
Cells expressing the ZCCHC11-specific or control nonspecific
shRNAswere then treatedwithHU, and replication-dependent
histone H3mRNA levels were determined by quantitative RT-
PCR (Fig. 2C). As expected, H3 mRNA was rapidly degraded
in the control shRNA-expressing cells within 30 min of HU
treatment. Expression of the ZCCHC11-specific shRNA largely
prevented the HU-induced decrease in histone mRNA level,
and this effect was attributable to knockdown of ZCCHC11,
as it was completely reversed by co-expression from a plasmid
of a ZCCHC11 cDNA lacking the 39 UTR sequence targeted
by the shRNA (Fig. 2A–C). A site-directed mutant version of
ZCCHC11 lacking two aspartate residues essential for catalysis
was unable to support HU-induced histone mRNA turnover
in this assay, indicating that ZCCHC11 catalytic activity is re-
quired for its mRNA destabilizing function. This function of
ZCCHC11 was not associated with any change in its abun-
dance, as judged by Western blotting (Fig. 2D).
Importantly, no such restoration of histone mRNA deg-
radation was seen on over-expression either of the other
FIGURE 1. ZCCHC11 is a cytoplasmic protein and specifically
associates with replication-dependent histone mRNAs. (A) Cytoplas-
mic (cyto) and nuclear HEK293T cell extracts were analyzed byWestern
blotting with a ZCCHC11-specific antibody. a-Tubulin and topoiso-
merase IIa served as controls for cytoplasmic and nuclear localization,
respectively. (B) ZCCHC11 was immunoprecipitated from cytoplasmic
extracts in the presence (+) or absence () of polyclonal anti-ZCCHC11
antibody. (C) Following formaldehyde cross-linking RNPs were im-
munoprecipitated (IP) using specific antibody or no antibody (ab).
Precipitates were subjected to RT-PCR using primers specific for the
ORF of replication-dependent histone HIST2H3 (H3). Products were
separated by agarose gel electrophoresis. M, molecular weight marker.
(D) As in C, but H3 mRNA (and GAPDH mRNA as a control) were
analyzed using real time RT-PCR. Data (mean of three biological rep-
licates,6SD) are expressed relative to the signal obtained in the absence
of specific antibody.
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known cytoplasmic terminal U-transferase ZCCHC6 or
of mitochondrial PAPD1, previously implicated in histone
mRNA turnover (data not shown). Equivalent results were
obtained forHIST2H2AmRNA (data not shown), indicating
a general requirement for ZCCHC11 in turnover of replica-
tion-dependent histone mRNAs following exposure to HU.
Reduced histone mRNA uridylation on ZCCHC11
knockdown
The requirement for the catalytic activity of this RNA ter-
minal uridyl transferase in histone mRNA destabilization
suggested that ZCCHC11 might be directly responsible for
the previously observed uridylation of histone mRNAs
(Mullen and Marzluff 2008). To address this possibility, we
used a circularized rapid amplification of cDNA ends
(cRACE) approach to detect terminal uridylation of histone
mRNAs and to determine the effect of ZCCHC11 knock-
down on these sequences (Fig. 3A). Our initial experiments
recapitulated those described in an earlier study (Mullen and
Marzluff 2008) and used RNA prepared from asynchronous
HeLa cells. In our hands the frequency of histone mRNA
uridylation under these circumstances was too low to allow
a statistically robust investigation of its dependence on
ZCCHC11 activity. This low frequency suggests that urid-
ylated mRNAs are turned over very rapidly in vivo, consis-
tent with the documented roles of 39 UMP residues in
RNA turnover pathways. We therefore used instead RNA
from cells synchronized in late S phase by double thymidine
blockade and release. Under these circumstances, the variant
of the cRACE protocol using untreated RNA at the ligation
step (to selectively monitor de-capped degradation interme-
diates; Fig. 3A) yielded insufficient material for quantitative
analysis, although a few clones were isolated corresponding
to RNAs that had undergone extensive 39–59 degradation
and terminated in nontemplated uridyl residues. This obser-
vation suggests that 39 uridylation continues during histone
mRNA decay, and might serve, for example, to reinitiate
stalled exonucleolysis. Nonetheless, pretreatment of the RNA
with tobacco acid pyrophosphatase (TAP) to remove 59 caps
allowed the cloning and sequencing of substantial numbers
of HIST2H2AC cDNAs (Fig. 3B,C; Supplemental Table 1).
Approximately 30% of the 46 sequences included one or two
terminal nontemplated uridyl residues. It should be noted
that the UMP tails detected in our study would be too short
to allow their detection by oligo(dA)-primed reverse tran-
scription as used byMullen andMarzluff (2008); the fact that
we did not observe longer oligo(U) tails suggests that such
tails are comparatively rare and/or unstable.
When the cRACE protocol was carried out using TAP-
treated RNA from cells in which ZCCHC11 had been
knocked down, there was an almost twofold reduction in
the proportion of uridylated sequences (P = 0.15, x2 test).
These data are consistent with the notion that HIST2H2AC,
and by inference other replication-dependent histone genes,
are direct targets of the ZCCHC11 uridyl transferase. The
lack of a larger effect may be due to incomplete ZCCHC11
FIGURE 2. ZCCHC11 is required for efficient degradation of replica-
tion-dependent histone mRNAs upon inhibition of DNA replication.
(A,B) ZCCHC11 was knocked down using shRNAs directed against its
39 UTR. A scrambled shRNA control (ctrl) was used in parallel. Forty-
eight hours following shRNA transfection, HEK293T cells were trans-
fected with either empty (e),WT, or catalytically inactive mutant (mut)
ZCCHC11 expression vector as indicated. The expression of ZCCHC11
was analyzed by Western blot using anti-ZCCHC11 (and anti-tubulin
as a control; A) and by quantitative RT-PCR (B) 72 h after shRNA
transfection. (C) As inB, but cells were treated with (+) or without () 5
mM hydroxyurea (HU) for 30 min before being harvested. Total RNA
was isolated and analyzed by real time RT-PCR. H3 mRNA values
(mean of five biological replicates 6SD) were normalized to GAPDH
mRNA and expressed relative to the RNA amount in untreated samples,
which was arbitrarily set to 1.0. (D) ZCCHC11 levels (and a-tubulin as
a loading control) were monitored by Western blotting extracts of cells
treated (+) or untreated () with 5 mM HU for 30 min.
FIGURE 3. The impact of ZCCHC11 knockdown on histone mRNA
uridylation. (A) Overview of the cRACE procedure used to capture
capped HIST2H2AC transcripts (black) and degradation intermedi-
ates (gray). Arrows indicate the position of the PCR primers used. (B)
cRACE was performed on TAP-treated RNA isolated from HeLa cells
harvested at the end of S phase following shRNA plasmid transfection.
The percentage of cRACE products containing terminal uridyl residues
is shown for control and ZCCHC11 knockdown cells (n = 14/46, 8/48,
respectively). (C) Diagram indicating the positions of uridyl residues
detected by cRACE.
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knockdown, or functional redundancy between ZCCHC11
and other uridyl transferases, even though ZCCHC11 knock-
down alone was sufficient to stabilize histone mRNAs
significantly.
Knockdown of PAPD1 or PAPD5 has no effect
of histone mRNA turnover
Given their reported function in histone mRNA turnover
(Mullen andMarzluff 2008), we performed assays analogous
to those described above using shRNAs specific for PAPD1
or PAPD5 (Fig. 4A). Although the extent of knockdown in
each case was comparable to that achieved with ZCCHC11
(Supplemental Table 2), and PAPD1 knockdown resulted
in decreased abundance of mitochondrial cytochrome oxi-
dase mRNA (Supplemental Fig. 1), as reported previously
(Nagaike et al. 2005), neither shRNA had any significant
impact on HU-induced histone mRNA destabilization. Our
data are therefore at odds with those previously described,
also using HeLa cells, which implicated PAPD1 and PAPD5,
but not ZCCHC11, in this process (Mullen and Marzluff
2008). The reason for this discrepancy is currently unclear,
but given the involvement of 39 uridylation in the histone
mRNA turnover pathway, it is easier to envisage a role in
this pathway for the cytoplasmic terminal U-transferase
ZCCHC11 than for the poly(A) polymerases PAPD1 or
PAPD5, especially as the former is a mitochondrial enzyme.
In linewith earlier studies that identified roles for the Lsm1
protein, and by extension the cytoplasmic Lsm1–7 hepta-
meric complex, in uridylation-dependent mRNA degrada-
tion in human cells and fission yeast (Mullen and Marzluff
2008; Rissland and Norbury 2009), we found that expression
of an Lsm1-specific shRNA in HEK293T cells abolished
the HU-induced histone mRNA destabilization (Fig. 4A).
This RNA turnover pathway does not appear to operate only
under the nonphysiological condition of HU exposure, as
steady-state histone H3 mRNA levels were significantly
elevated in asynchronous cell populations expressing shRNAs
targeting ZCCHC11 or Lsm1 (Fig. 4B). Again, knockdown of
PAPD1 or PAPD5 had no such effect.
ZCCHC11 expression declines during
S phase progression
As ZCCHC11 is required for histone mRNA regulation, we
investigated the possibility that it might itself be regulated in
some way during S phase progression. HeLa cells were
synchronized by double thymidine block and release (Fig.
5A), and mRNA levels were monitored during the sub-
sequent progression through S phase. As expected, histone
H3 mRNA levels rose to a peak by four hours after release,
when cells were in mid-S phase. In contrast, ZCCHC11
mRNA and protein levels declined slightly by this time point,
but subsequently recovered as cells completed S phase (Fig.
5B). This pattern of expression would be consistent with
suppression of ZCCHC11 activity during S phase progres-
sion and a physiological role for this activity in the degrada-
tion of histonemRNAs on completion ofDNA replication, as
suggested by our observation of histone mRNA accumula-
tion on ZCCHC11 knockdown in asynchronous cells (Fig.
4B). Comparable S phase-specific regulation was not seen in
the case of PAPD1, expression of which increased steadily on
release from the thymidine block, or of PAPD5, which was
expressed at a constant level (Fig. 5B).
ZCCHC11 was previously found to be responsible for the
uridylation of cytoplasmic pre-miRNAs on recruitment by
its RNA-binding partner Lin28, and for the uridylation of
maturemiRNAs in such a way as to influence their biological
activity. To exclude the possibility that the ZCCHC11-
dependent effect on histone mRNA turnover is mediated
indirectly via miRNAs, we knocked down the Drosha
ribonuclease in order to inhibit miRNA maturation. We
did not observe any changes in the rate of histone mRNA
degradation upon S phase arrest under these conditions
(Supplemental Fig. 2) or any change in steady-state histone
mRNA levels (Fig. 4B). In addition to the role of ZCCHC11
in miRNA regulation, our data clearly implicate the same
enzyme in a uridylation-dependent pathway of histone
mRNA turnover. The biological significance of the combi-
nation of these two important regulatory activities in a
single RNA uridyl transferase awaits further clarification.
ZCCHC11 does not display inherent substrate specificity
(Jones et al. 2009), suggesting the involvement of other
factors in targeting specific RNAs. It will be interesting to
FIGURE 4. Effect of PAPD1 and PAPD5 knockdown on the degrada-
tion of replication-dependent histone mRNAs upon S phase arrest. (A)
HEK293T cells were transfected with control (ctrl) or specific shRNAs
directed against PAPD1, PAPD5, or Lsm1. Seventy-two hours after trans-
fection, cells were treated with (+) or without () 5 mM hydroxyurea
(HU) for 30 min. RNA was analyzed as in Figure 2C. The mean of at
least three biological replicates 6SD is indicated. (B) Steady-state H3
mRNA levels in asynchronous cells transfected with the shRNA ex-
pression vectors indicated were compared to those in cells expressing the
scrambled control shRNA (ctrl).
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determine whether there is a functional analog of Lin28 that
recruits ZCCHC11 to histone mRNAs. Further studies may
also help to explain the significance of the comparatively
large size of ZCCHC11, and its possession of zinc finger
motifs and a duplication of the catalytic domain, while only
one of the domains retains amino acid residues critical for
activity.
Amino acid sequence comparisons and biochemical as-
says suggest that the ZCCHC6 protein might perform
ZCCHC11-like roles, but these do not seem to relate to
turnover of the histone mRNAs examined here. It will be
interesting to determine whether either of these enzymes is
also involved in the uridylation and turnover of polyadenyl-
ated mRNAs, as is the related uridyl transferase Cid1 in
fission yeast (Rissland and Norbury 2009).
MATERIALS AND METHODS
Oligonucleotides
Sequences of oligonucleotides used for cloning, site-directed muta-
genesis, and shRNA expression are given in Supplemental Table 3.
Plasmids
All shRNA expression plasmids were generated by inserting re-
spective annealed oligonucleotides into the pre-linearized siSTRIKE
vector (Promega). To create pcDNA-ZCCHC11-TAP, ZCCHC11
was amplified from clone KIAA0191 (Kazusa Research Institute)
using oligonucleotides SacIIHC11f and NotIHC11r and the pro-
cedure described previously (Rissland et al. 2007). Site-directed
mutagenesis using oligonucleotides HC11DADAf and HC11DADAr
with plasmid pcDNA-ZCCHC11-TAP was used to create a derivative
encoding catalytically inactive ZCCHC11.
RNAi
HEK293T cells were transfected with 5 mg of siSTRIKE plasmid
(Promega) expressing specific shRNA or a scrambled shRNA
control using Lipofectamine 2000 (Invitrogen). The efficiency of
the RNAi was monitored by real time RT-PCR using specific
oligonucleotides. Two micrograms of pcDNA-ZCCHC11-TAP
was used for subsequent transfection when needed. Seventy-two
hours after siSTRIKE transfection, cells were treated with 5 mM
HU for 30 min and harvested at 4°C.
RNA isolation and RT-PCR
Total RNA was isolated using Tri-reagent (Sigma-Aldrich). Con-
taminating DNA was removed by DNase treatment (Promega). Re-
verse transcription was performed using Superscript III and 10 pmol
random hexamers (Invitrogen) according to the manufacturer’s
guidelines. Five microliters of SYBR Green mix (Bioline) and one
twentieth of the cDNA were used for subsequent real time PCR
reactions. For each sample, a control reaction was performed in the
absence of reverse transcriptase. All RNA levels were normalized to
GAPDH mRNA.
Circularized rapid amplification of cDNA
ends analysis
cRACE was performed as described previously (Mullen and
Marzluff 2008; Rissland and Norbury 2009). In brief, capped
transcripts were captured by treating RNA with tobacco acid
pyrophosphatase prior to RNA circularization. Half of the ligation
was subjected to cDNA synthesis using primer H2cRACE-r. One
twentieth of the cDNA was amplified by PCR using oligonucle-
otides H2-f and H2cRACE-r for 30 cycles. PCR products were
cloned and sequenced.
ZCCHC11 immunoprecipitation
ZCCHC11 was immunoprecipitated as described (Dostie and
Dreyfuss 2002) using anti-ZCCHC11. RNA immunoprecipitation
experiments were performed as described (West and Proudfoot
2008); immunoprecipitation was performed for two hours using
anti-ZCCHC6 or anti-ZCCHC11.
Human cell synchronization
HeLa cells were synchronized using a double thymidine block as
described (Whitfield et al. 2000). Upon release of the block, total
RNA was isolated at time points indicated. The DNA content of
the cells was determined by flow cytometry (FACScan, Becton
Dickinson) of propidium iodide stained cells.
Cell fractionation and Western blot analysis
Total protein extracts were obtained by resuspension of cell pellets
in RIPA buffer (15 mM NaCl, 1% Triton X-100, 0.5% sodium
deoxycholate, 0.1% SDS, and 10% glycerol [v/v]) including
FIGURE 5. ZCCHC11 expression negatively correlates with H3
expression during S phase. HeLa cells were blocked in early S phase
by a double thymidine block and then released. (A) The cell cycle
distribution of propidium iodide stained cells was analyzed by flow
cytometry at the indicated times after release from the block, and in
asynchronous cells. (B) Upon removal of the block, total RNA was
isolated at time points indicated and analyzed by real time RT-PCR
using specific oligonucleotides. H3 and ZCCHC11 (upper panel) and
H3, PAPD1, and PAPD5 (middle panel) mRNA levels were normal-
ized to GAPDH mRNA and expressed in relation to RNA obtained
from cells at the time when the block was removed (0 h). ZCCHC11
and a-tubulin protein levels were measured by Western blotting at the
same time points (lower panel).
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protease inhibitors. Cell fractionation was performed as described
(West et al. 2008). After centrifugation, cytoplasmic extracts were
obtained from the top 0.2 mL while nuclear pellets were resus-
pended in 0.2 mL RIPA buffer.
Western blotting was performed using ECL (Santa Cruz Bio-
technology). Antibodies against a-tubulin (TAT-1) and topoiso-
merase IIa were generous gifts from Keith Gull and Ian Hickson,
respectively.
Preparation of ZCCHC6 and ZCCHC11 antibodies
Polyclonal antibodies were raised against recombinant peptides of
ZCCHC6 and ZCCHC11 encoded by nucleotides 1920–2480 and
160–720 of the open reading frame, respectively. Immunoglobulins
were purified from crude serum by preparative Western blotting.
In brief, the recombinant GST-tagged peptide was expressed and
purified essentially as described previously (Rissland et al. 2007) but
eluted from glutathione-Sepharose using 25 mM glutathione.
Eluted protein was transferred to a PVDF membrane, which was
incubated overnight with 2 mL of crude serum. The bound anti-
body was eluted using 1 mL of 0.1 M glycine (pH 2.5) and sub-
sequently neutralized with 120 mL of 1 M Tris pH 8.0.
SUPPLEMENTAL MATERIAL
Supplemental material can be found at http://www.rnajournal.org.
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